Since oxidative stress is associated with many pathological conditions, such as cancer, neurodegenerative diseases, cardiovascular diseases, and metabolic diseases [36,37], clinical applications targeting the Nrf2 pathway are attracting increasing interest [38]. The gene discussed is NFE2L2; the disease is neurodegenerative disease.